Could a sweetener stop deadly infections in transplant kids?
NCT ID NCT05579639
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special wipe containing xylitol, a natural sweetener, can reduce dangerous bloodstream infections in children and young adults undergoing stem cell transplants. These infections often start from bacteria in the mouth and can be life-threatening. Participants will be randomly assigned to receive either the xylitol wipe or a placebo wipe twice daily during their hospital stay.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Dana-Farber/Boston Children's
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could tailor CMV prevention after stem cell transplants
- New scan could spot hidden scarring in heart and lungs before It's too late
- New hope for older leukemia patients: drug may keep cancer away after transplant
- Tailored transplant doses aim to beat blood cancer
- Promising cancer drug trial pulled before it even started
- Lower-Dose drug may make stem cell transplants safer for blood cancer patients